Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gregor Schaffar
Observed names:
G. Schaffar,
Schaffar, G.,
Schaffar, Gregor
Institution:
Hexal (Germany)
Observed institutions:
National Institutes of Health,
Max Planck Society,
Hexal (Germany),
Brain (Germany),
Abbott (Germany),
Max Planck Institute for Molecular Genetics,
Max Planck Institute of Biochemistry
show all 7
OpenAlex ID:
A5021224331
Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
2000
·
Paul J. Muchowski
, Gregor Schaffar
, et al.
·
Proceedings of the National Academy of Sciences
·
735
Cellular Toxicity of Polyglutamine Expansion Proteins
2004
·
Gregor Schaffar
, Peter Breuer
, et al.
·
Molecular Cell
·
489
PDF
Roles of molecular chaperones in protein misfolding diseases
2004
·
José M Barral
, Sarah A Broadley
, et al.
·
Seminars in Cell and Developmental Biology
·
336
Chaperonin TRiC Promotes the Assembly of polyQ Expansion Proteins into Nontoxic Oligomers
2006
·
Christian Behrends
, Carola A. Langer
, et al.
·
Molecular Cell
·
305
PDF
Studying interactions of four proteins in the yeast two-hybrid system: Structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein
1999
·
Arnim Pause
, Brett Peterson
, et al.
·
Proceedings of the National Academy of Sciences
·
111
Single particle detection and characterization of synuclein co-aggregation
2005
·
Armin Giese
, Benedikt Bader
, et al.
·
Biochemical and Biophysical Research Communications
·
58
The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system
2006
·
Bernhard K Mueller
, Toshihide Yamashita
, et al.
·
Philosophical Transactions of the Royal Society B Biological Sciences
·
56
A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial
2016
·
Kimberly Blackwell
, Roman Donskih
, et al.
·
The Oncologist
·
41
PDF
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs
2019
·
Francesca Civoli
, Aparna Kasinath
, et al.
·
The AAPS Journal
·
37
LIM‐only protein 4 interacts directly with the repulsive guidance molecule A receptor Neogenin
2008
·
Gregor Schaffar
, Junko Taniguchi
, et al.
·
Journal of Neurochemistry
·
34
Proposed biosimilar pegfilgrastim shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects
2018
·
Roumen Nakov
, Sreekanth Gattu
, et al.
·
British Journal of Clinical Pharmacology
·
21
PDF
A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
2017
·
Matthew R. Weir
, Pablo E. Pergola
, et al.
·
American Journal of Nephrology
·
13
Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients
2017
·
Nicole Casadevall
, Vladimir Dobronravov
, et al.
·
Clinical Nephrology
·
11
PDF
Now we are talking sense! Functional approaches to novel nutraceuticals and cosmeceuticals
2008
·
Michael Krohn
, Alice Kleber
, et al.
·
Biotechnology Journal
·
7
State‐of‐the‐art immunogenicity evaluation in phase 3 confirmatory study ( EGALITY ) with etanercept biosimilar GP 2015
2017
·
J. Poetzl
, I. Arlt
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
5
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)
2022
·
Sanjiv S. Agarwala
, Ulrich Nagl
, et al.
·
Current Medical Research and Opinion
·
3
PDF
Semin. Cell Dev. Biol.
2004
·
Barral, J.
, Broadley, S.
, et al.
·
MPG.PuRe (Max Planck Society)
·
2
A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006)
2022
·
Agarwala, Sanjiv S.
, Nagl, Ulrich
, et al.
·
Figshare
Supplementary Material for: A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
2017
·
Weir, M.R.
, Pergola, P.E.
, et al.
·
Figshare
Sp312evaluation of the Safety and Immunogenicity of Subcutaneous (sc) Hx575 Epoetin Alfa in the Treatment of Anaemia Associated With Ckd
2016
·
Nicole Casadevall
, Vladimir Dobronravov
, et al.
·
Nephrology Dialysis Transplantation
Soluble polyQ protein impairs transcription factor function in a yeast model system
2005
·
Christian Behrends
, Gregor Schaffar
, et al.
Mol. Cell
2004
·
Schaffar, G.
, Breuer, P.
, et al.
·
MPG.PuRe (Max Planck Society)
Berührungslose Messung von Wasserschichtdicke und Salzgehalt auf Strassen
1987
·
S. Hertl
, G. Schaffar
·
Springer eBooks
Berührungslose Messung von Wasserschichtdicke und Salzgehalt auf Strassen
1987
·
S. Hertl
, G. Schaffar
·
Springer eBooks
Mikroelektronik 87
1987
·
G. Hoffmann
, D. Holzmann
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
25
Citation count:
2,264
H-index:
12
I10-index:
13
Year
Topic
Type